269 related articles for article (PubMed ID: 33217370)
1. Statin Therapy for Primary Prevention in the Elderly and Its Association with New-Onset Diabetes, Cardiovascular Events, and All-Cause Mortality.
Lavie G; Hoshen M; Leibowitz M; Benis A; Akriv A; Balicer R; Reges O
Am J Med; 2021 May; 134(5):643-652. PubMed ID: 33217370
[TBL] [Abstract][Full Text] [Related]
2. Compliance in Primary Prevention With Statins and Associations With Cardiovascular Risk and Death in a Low-Risk Population With Type 2 Diabetes Mellitus.
Malmborg M; Schmiegelow MDS; Gerds T; Schou M; Kistorp C; Torp-Pedersen C; Gislason G
J Am Heart Assoc; 2021 Jul; 10(13):e020395. PubMed ID: 34151606
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands.
de Vries FM; Denig P; Visser ST; Hak E; Postma MJ
Value Health; 2014 Mar; 17(2):223-30. PubMed ID: 24636380
[TBL] [Abstract][Full Text] [Related]
4. Time- and Dose-Dependent Association of Statin Use With Risk of Clinically Relevant New-Onset Diabetes Mellitus in Primary Prevention: A Nationwide Observational Cohort Study.
Ko MJ; Jo AJ; Kim YJ; Kang SH; Cho S; Jo SH; Park CY; Yun SC; Lee WJ; Park DW
J Am Heart Assoc; 2019 Apr; 8(8):e011320. PubMed ID: 30982384
[TBL] [Abstract][Full Text] [Related]
5. Statins and New-Onset Diabetes Mellitus and Diabetic Complications: A Retrospective Cohort Study of US Healthy Adults.
Mansi I; Frei CR; Wang CP; Mortensen EM
J Gen Intern Med; 2015 Nov; 30(11):1599-610. PubMed ID: 25917657
[TBL] [Abstract][Full Text] [Related]
6. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.
Ramos R; Comas-Cufí M; Martí-Lluch R; Balló E; Ponjoan A; Alves-Cabratosa L; Blanch J; Marrugat J; Elosua R; Grau M; Elosua-Bayes M; García-Ortiz L; Garcia-Gil M
BMJ; 2018 Sep; 362():k3359. PubMed ID: 30185425
[TBL] [Abstract][Full Text] [Related]
7. Statin therapy and related risk of new-onset type 2 diabetes mellitus.
Ruscica M; Macchi C; Morlotti B; Sirtori CR; Magni P
Eur J Intern Med; 2014 Jun; 25(5):401-6. PubMed ID: 24685426
[TBL] [Abstract][Full Text] [Related]
8. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.
Izzo R; de Simone G; Trimarco V; Giudice R; De Marco M; Di Renzo G; De Luca N; Trimarco B
Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1101-6. PubMed ID: 23419735
[TBL] [Abstract][Full Text] [Related]
9. Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland.
Rannanheimo PK; Tiittanen P; Hartikainen J; Helin-Salmivaara A; Huupponen R; Vahtera J; Korhonen MJ
Value Health; 2015 Sep; 18(6):896-905. PubMed ID: 26409618
[TBL] [Abstract][Full Text] [Related]
10. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.
Awad K; Mohammed M; Zaki MM; Abushouk AI; Lip GYH; Blaha MJ; Lavie CJ; Toth PP; Jukema JW; Sattar N; Banach M;
BMC Med; 2021 Jun; 19(1):139. PubMed ID: 34154589
[TBL] [Abstract][Full Text] [Related]
11. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
Lavie G; Cohen S
Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
[TBL] [Abstract][Full Text] [Related]
12. Statin Therapy: Diabetes Mellitus Risk and Cardiovascular Benefit in Primary Prevention.
Porath A; Arbelle JE; Fund N; Cohen A; Mosseri M
Isr Med Assoc J; 2018 Aug; 20(8):480-485. PubMed ID: 30084572
[TBL] [Abstract][Full Text] [Related]
13. Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention.
Rochlani Y; Kattoor AJ; Pothineni NV; Palagiri RDR; Romeo F; Mehta JL
Am J Cardiol; 2017 Oct; 120(7):1122-1128. PubMed ID: 28797470
[TBL] [Abstract][Full Text] [Related]
14. Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China.
Zhao B; He X; Wu J; Yan S
BMC Cardiovasc Disord; 2020 Jun; 20(1):282. PubMed ID: 32522146
[TBL] [Abstract][Full Text] [Related]
15. Statin Use in Older Adults for Primary Cardiovascular Disease Prevention Across a Spectrum of Cardiovascular Risk.
Sarraju A; Spencer-Bonilla G; Chung S; Gomez S; Li J; Heidenreich P; Palaniappan L; Rodriguez F
J Gen Intern Med; 2022 Aug; 37(11):2642-2649. PubMed ID: 34505981
[TBL] [Abstract][Full Text] [Related]
16. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
Nanna MG; Navar AM; Wang TY; Mi X; Virani SS; Louie MJ; Lee LV; Goldberg AC; Roger VL; Robinson J; Peterson ED
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739801
[TBL] [Abstract][Full Text] [Related]
17. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Outcomes of Short-Term Statin Use in Healthy Adults: A Retrospective Cohort Study.
Mansi IA; English J; Zhang S; Mortensen EM; Halm EA
Drug Saf; 2016 Jun; 39(6):543-59. PubMed ID: 26979831
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effect of discontinuing statins for primary prevention at the age of 75 years: a nationwide population-based cohort study in France.
Giral P; Neumann A; Weill A; Coste J
Eur Heart J; 2019 Nov; 40(43):3516-3525. PubMed ID: 31362307
[TBL] [Abstract][Full Text] [Related]
20. Moderate-intensity statin use for primary prevention for more than 5 years is associated with decreased all-cause mortality in 75 years and older.
Kim S; Choi H; Won CW
Arch Gerontol Geriatr; 2022; 100():104644. PubMed ID: 35121242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
